International Journal of Molecular Medical Science, 2025, Vol.15, No.5, 205-213 http://medscipublisher.com/index.php/ijmms 212 Chen L., Liu W., Lin H., Lin M., Yu Y., Liu H., Dai Y., Chen L., Jia W., He X., Li X., Zhu J., Xue X., and Tao J., 2022, Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer’s disease: a meta-analysis and systematic review, Neural Regeneration Research, 17: 2381-2390. https://doi.org/10.4103/1673-5374.335832 Dave N., Lee M., Pavlou H., Im O., Goh K., Ulin S., Malzbender K., Shobin E., and Sukumar A., 2025, Unlocking ocular biomarkers for early detection of Alzheimer's disease, Alzheimer's and Dementia, 21(2): e14567. https://doi.org/10.1002/alz.14567 Dhauria M., Mondal R., Deb S., Shome G., Chowdhury D., Sarkar S., and Benito-León J., 2024, Blood-based biomarkers in Alzheimer’s disease: advancing non-invasive diagnostics and prognostics, International Journal of Molecular Sciences, 25(20): 10911. https://doi.org/10.3390/ijms252010911 Gao F., Dai L., Wang Q., Liu C., Deng K., Cheng Z., Lü X., Wu Y., Zhang Z., Tao Q., Yuan J., Li S., Wang Y., Su Y., Cheng X., Ni J., Wu Z., Zhang S., Shi J., and Shen Y., 2023, Blood-based biomarkers for Alzheimer's disease: a multicenter-based cross-sectional and longitudinal study in China, Science Bulletin, 68(16): 1800-1808. https://doi.org/10.1016/j.scib.2023.07.009 Gaubert S., Houot M., Raimondo F., Ansart M., Corsi M., Naccache L., Sitt J., Habert M., Dubois B., Fallani F., Durrleman S., and Epelbaum S., 2021, A machine learning approach to screen for preclinical Alzheimer's disease, Neurobiology of Aging, 105: 205-216. https://doi.org/10.1016/j.neurobiolaging.2021.04.024 Ghazi M., Selnes P., Timón-Reina S., Tecelão S., Ingala S., Bjørnerud A., Kirsebom B., Fladby T., and Nielsen M., 2024, Comparative analysis of multimodal biomarkers for amyloid-beta positivity detection in Alzheimer's disease cohorts, Frontiers in Aging Neuroscience, 16: 1345417. https://doi.org/10.3389/fnagi.2024.1345417 Grande G., Valletta M., Rizzuto D., Xia X., Qiu C., Orsini N., Dale M., Andersson S., Fredolini C., Winblad B., Laukka E., Fratiglioni L., and Vetrano D., 2025, Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community, Nature Medicine, 31: 2027-2035. https://doi.org/10.1038/s41591-025-03605-x Gunes S., Aizawa Y., Sugashi T., Sugimoto M., and Rodrigues P., 2022, Biomarkers for Alzheimer’s disease in the current state: a narrative review, International Journal of Molecular Sciences, 23(9): 4962. https://doi.org/10.3390/ijms23094962 Guo H., 2025 Emerging genomic biomarkers for early detection of oral cancer, International Journal of Molecular Medical Science, 15(1): 9-19. https://doi.org/10.5376/ijmms.2025.15.0002 Hansson O., Blennow K., Zetterberg H., and Dage J., 2023, Blood biomarkers for Alzheimer’s disease in clinical practice and trials, Nature Aging, 3: 506-519. https://doi.org/10.1038/s43587-023-00403-3 Hechkel W., and Helali A., 2024, Unveiling alzheimer’s disease early: a comprehensive review of machine learning and imaging techniques, Archives of Computational Methods in Engineering, 32(1): 471-484. https://doi.org/10.1007/s11831-024-10179-3 Heneka M., Gauthier S., Chandekar S., Hahn-Pedersen J., Bentsen M., and Zetterberg H., 2025, Neuroinflammatory fluid biomarkers in patients with Alzheimer’s disease: a systematic literature review, Molecular Psychiatry, 30: 2783-2798. https://doi.org/10.1038/s41380-025-02939-9 Hong X., Huang L., Lei F., Li T., Luo Y., Zeng M., and Wang Z., 2025, The role and pathogenesis of tau protein in Alzheimer’s disease, Biomolecules, 15(6): 824. https://doi.org/10.3390/biom15060824 Jamal R., Shaikh M., Taleuzzaman M., Haque Z., Albratty M., Alam M., Makeen H., Zoghebi K., and Saleh S., 2025, Key biomarkers in Alzheimer’s disease: Insights for diagnosis and treatment strategies, Journal of Alzheimer's Disease, 105: 679-696. https://doi.org/10.1177/13872877251330500 Jiao C., Gao Y., Ge D., Shang J., and Liu J., 2024, Multi-modal imaging genetics data fusion by deep auto-encoder and self-representation network for Alzheimer's disease diagnosis and biomarkers extraction, Eng. Appl. Artif. Intell., 130: 107782. https://doi.org/10.1016/j.engappai.2023.107782 Kale M., Wankhede N., Pawar R., Ballal S., Kumawat R., Goswami M., Khalid M., Taksande B., Upaganlawar A., Umekar M., Kopalli S., and Koppula S., 2024, AI-driven innovations in Alzheimer's disease: integrating early diagnosis personalized treatment and prognostic modelling, Ageing Research Reviews, 101: 102497. https://doi.org/10.1016/j.arr.2024.102497 Kim K., Kim M., Kim D., Kim S., Park S., and Park C., 2020, Clinically accurate diagnosis of Alzheimer’s disease via multiplexed sensing of core biomarkers in human plasma, Nature Communications, 11(1): 119. https://doi.org/10.1038/s41467-019-13901-z Klyucherev T., Olszewski P., Shalimova A., Chubarev V., Tarasov V., Attwood M., Syvänen S., and Schiöth H., 2022, Advances in the development of new biomarkers for Alzheimer’s disease, Translational Neurodegeneration, 11(1): 25. https://doi.org/10.1186/s40035-022-00296-z Lou Q.Y., and Xu X.Y., 2025 The changes in blood exosomal miRNA Profiles and disease progression in alzheimer’s disease patients, International Journal of Molecular Medical Science, 15(4): 175-184. https://doi.org/10.5376/ijmms.2025.15.0018
RkJQdWJsaXNoZXIy MjQ4ODYzNA==